P
Pacific Biosciences
Long-Read Sequencing Technology
Menlo Park, CA
1,200+
About Pacific Biosciences
Industry:
Genomics
Founded:
2004
Founders:
Stephen Turner, Jonas Korlach
Status:
Public (NASDAQ: PACB)
Funding & Growth
Total Raised:
$800M+
Valuation:
$3B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Leading long-read technology
- • Innovative science
- • Bay Area location
- • Strong R&D culture
- • Growing market share
✗ Cons
- • Stock volatility
- • Competition with ONT
- • Smaller company resources
- • Cost of instruments